Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs01869292
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
GSL | (2S,3R)-3-HYDROXY-2-(TETRADECANOYLAMINO)OCTADECYL ALPHA- D-GALACTOPYRANOSIDURONIC ACID | A | 2FIK | 0.72 | |
CR6 | 1-DEOXY-1-ACETYLAMINO-BETA-D-GLUCO- 2-HEPTULOPYRANOSONAMIDE | A | 1P4H | 0.71 | |
CR6 | 1-DEOXY-1-ACETYLAMINO-BETA-D-GLUCO- 2-HEPTULOPYRANOSONAMIDE | A | 1FU8 | 0.71 | |
TNR | O-(2-ACETAMIDO-2-DEOXY-ALPHA-D- GALACTOPYRANOSYL)-L-SERINE | A,B,C,D | 1N47 | 0.72 | |
TNR | O-(2-ACETAMIDO-2-DEOXY-ALPHA-D- GALACTOPYRANOSYL)-L-SERINE | A | 2CGZ | 0.72 | |
TNR | O-(2-ACETAMIDO-2-DEOXY-ALPHA-D- GALACTOPYRANOSYL)-L-SERINE | A,B,C,D | 2D3S | 0.72 | |
TNR | O-(2-ACETAMIDO-2-DEOXY-ALPHA-D- GALACTOPYRANOSYL)-L-SERINE | A | 2D7R | 0.72 | |
GTH | 3-O-GLUCOPYRANOSYL-THREONINE-[2- DEOXY-2-ACETAMIDO-GLUCOPYRANOSIDE] | A | 1WCT | 0.72 | |
B31 | (2S)-4-amino-N-[(1R,2S,3R,4R,5S)- 5-amino-4-[(2,6-diamino-2,6-dideoxy- alpha-D-glucopyranosyl)oxy]-2-hydroxy- 3-(beta-D-xylofuranosyloxy)cyclohexyl]- 2-hydroxybutanamide | A | 3H8P | 0.71 | |
BLG | 4-O-(4-O-SULFONYL-N-ACETYLGLUCOSAMININYL)- 5-METHYLHYDROXY-L-PROLINE-TAURINE | A | 1D0M | 0.71 | |
BLG | 4-O-(4-O-SULFONYL-N-ACETYLGLUCOSAMININYL)- 5-METHYLHYDROXY-L-PROLINE-TAURINE | A | 1D0L | 0.71 | |
BLG | 4-O-(4-O-SULFONYL-N-ACETYLGLUCOSAMININYL)- 5-METHYLHYDROXY-L-PROLINE-TAURINE | A | 1SLY | 0.71 | |
AB9 | (2R)-4-AMINO-N-{(1R,2S,3R,4R,5S)- 5-AMINO-2-{2-[(2-AMINOETHYL)AMINO]ETHOXY}- 4-[(2,6-DIAMINO-2,6-DIDEOXY-ALPHA- D-GLUCOPYRANOSYL)OXY]-3-HYDROXYCYCLOHEXYL}- 2-HYDROXYBUTANAMIDE | A,D,M,N,Z | 2F4V | 0.71 | |
AB9 | (2R)-4-AMINO-N-{(1R,2S,3R,4R,5S)- 5-AMINO-2-{2-[(2-AMINOETHYL)AMINO]ETHOXY}- 4-[(2,6-DIAMINO-2,6-DIDEOXY-ALPHA- D-GLUCOPYRANOSYL)OXY]-3-HYDROXYCYCLOHEXYL}- 2-HYDROXYBUTANAMIDE | B | 2F4T | 0.71 | |
AH0 | 2-(2-ACETYLAMINO-4-HYDROXY-6,8- DIOXA-BICYCLO[3.2.1]OCT-3-YLOXY)- PROPIONIC ACID | A | 1QTE | 0.72 | |
MGS | 1,2-O-DIMETHYL-4-[2,4-DIHYDROXY- BUTYRAMIDO]-4,6-DIDEOXY-ALPHA-D- MANNOPYRANOSIDE | H | 1F4X | 0.72 | |
BUL | BULGECIN A | A | 1LMC | 0.71 | |
BUL | BULGECIN A | A | 1LSP | 0.71 | |
NXD | METHYL 5-(ACETYLAMINO)-9-{[AMINO(OXO)ACETYL]AMINO}- 3,5,9-TRIDEOXY-D-GLYCERO-ALPHA- D-GLUCO-NON-2-ULOPYRANOSIDONIC ACID | A | 2G5R | 0.73 | |
MMR | N-((2R,3R,4S,6S)-6-(HYDROXYMETHYL)- 2-METHOXY-4-((S)-1-OXOPROPAN-2- YLOXY)TETRAHYDRO-2H-PYRAN-3-YL)ETHANAMIDE | L | 2EAX | 0.7 | |
MU2 | N-ACETYLMURAMYL-L-ALANYL-D-ISOGLUTAMINE | A | 2IXV | 0.74 | |
MU2 | N-ACETYLMURAMYL-L-ALANYL-D-ISOGLUTAMINE | A | 2IXU | 0.74 | |
MGU | 2-O-[2-O-METHYL-4-[2,4-DIHYDROXY- BUTYRAMIDO]-4,6-DIDEOXY-]-ALPHA- D-MANNOPYRANOSYL-[1-O-METHYL-4- [2,4-DIHYDROXY-BUTYRAMIDO]-4,6- DIDEOXY]-ALPHA-D-MANNOPYRANOSE | H | 1F4Y | 0.71 | |
AMV | METHYL 2-(ACETYLAMINO)-3-O-[(1R)- 1-CARBOXYETHYL]-2-DEOXY-BETA-D- GLUCOPYRANOSIDE | A | 2J8G | 0.71 | |
AMV | METHYL 2-(ACETYLAMINO)-3-O-[(1R)- 1-CARBOXYETHYL]-2-DEOXY-BETA-D- GLUCOPYRANOSIDE | A | 2J8F | 0.71 | |
MLD | GLCNAC(BETA1-4)-MURNAC(1,6-ANHYDRO)- L-ALA-GAMMA-D-GLU-MESO-A2PM-D-ALA | A,X | 2F2L | 0.73 | |
MLD | GLCNAC(BETA1-4)-MURNAC(1,6-ANHYDRO)- L-ALA-GAMMA-D-GLU-MESO-A2PM-D-ALA | A,B,C,D | 2CB3 | 0.73 |